Gismo Therapeutics Inc. With a focus on fundamental biochemical processes, Gismo Therapeutics aims to address the root cause of these neurodegenerative diseases. Utilizing their groundbreaking technology, GISMO, the company has received prestigious research grants to further advance their industry-leading approach.

Gismo Therapeutics is dedicated to creating first-in-class, disease-modifying oral therapeutics for the treatment of both Alzheimer's and Parkinson's Disease. Their groundbreaking solutions have garnered attention and support from the scientific community, as evidenced by their grants and recognition. Stay updated with the latest news and developments in the field through Gismo Therapeutics' news and events section.

They have received grants for the development of novel therapeutics and have been recognized by the Michael J. Fox Foundation for Parkinson's Research. Gismo Therapeutics Inc